T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell

Area of Science:

• Stem cell biology
• Immunology
• Cancer research

Background:

• Cellular reprogramming converts mature cells to pluripotent stem cells, advancing regenerative medicine.
• Generating patient-specific stem cells minimizes immune rejection for therapeutics.
• The cell type used for reprogramming may influence the outcome, but this is not well understood.

Purpose of the Study:

• To investigate the biological consequences of reprogramming T cells into pluripotent stem cells.
• To determine if the cell of origin impacts the development of diseases post-reprogramming.
• To explore the role of T cell receptor (TCR) signaling in lymphomagenesis.

Main Methods:

• Generation of mice from reprogrammed T cells.
• Analysis of T cell receptor (TCR) gene rearrangement in all cells.
• Monitoring for spontaneous tumor development, specifically T cell lymphomas.
• Investigating the role of TCR signaling pathways in lymphoma proliferation using inhibitors.

Main Results:

• Mice derived from reprogrammed T cells exhibited prerearranged TCR genes in all cells.
• Approximately 50% of these mice developed spontaneous T cell lymphomas originating in the thymus.
• Lymphomagenesis was dependent on the expression of prerearranged TCRα and TCRβ genes, indicating a role for TCR signaling.
• Inhibitors of TCR signaling pathways suppressed lymphoma growth, confirming TCR signaling's importance in proliferation.

Conclusions:

• Reprogramming T cells can lead to T cell lymphomas due to misregulated TCR rearrangement and signaling.
• The identity of the cell of origin (T cell) has significant biological consequences in cellular reprogramming.
• TCR signaling plays a critical role in both the development and proliferation of these lymphomas.